Dermatophytosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dermatophytosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions... Research Beam Model: Research Beam Product ID: 153553 2500 USD New
Dermatophytosis Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Dermatophytosis Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 83
 
 
Dermatophytosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dermatophytosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dermatophytosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dermatophytosis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Dermatophytosis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Dermatophytosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Dermatophytosis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Merz Pharma GmbH & Co. KgaA 32
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 32
Valeant Pharmaceuticals International, Inc. 33
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 33
Sun Pharmaceutical Industries Limited 34
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
York Pharma Plc (Inactive) 36
Clinical Trial Overview of York Pharma Plc (Inactive) 36
Tinea Pharmaceuticals 37
Clinical Trial Overview of Tinea Pharmaceuticals 37
Quinnova Pharmaceuticals, Inc. 38
Clinical Trial Overview of Quinnova Pharmaceuticals, Inc. 38
AmDerma Pharmaceuticals, LLC. 39
Clinical Trial Overview of AmDerma Pharmaceuticals, LLC. 39
Perrigo Company plc 40
Clinical Trial Overview of Perrigo Company plc 40
NB Therapeutics, Inc. 41
Clinical Trial Overview of NB Therapeutics, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Department of Health, South Africa 42
Clinical Trial Overview of Department of Health, South Africa 42
Kurdistan University of Medical Sciences 43
Clinical Trial Overview of Kurdistan University of Medical Sciences 43
Oita University 44
Clinical Trial Overview of Oita University 44
Jamaica Hospital Medical Center 45
Clinical Trial Overview of Jamaica Hospital Medical Center 45
The Children's Mercy Hospital 46
Clinical Trial Overview of The Children's Mercy Hospital 46
Eastern Virginia Medical School 47
Clinical Trial Overview of Eastern Virginia Medical School 47
Katholieke Universiteit Leuven 48
Clinical Trial Overview of Katholieke Universiteit Leuven 48
Karolinska Institute 49
Clinical Trial Overview of Karolinska Institute 49
University of Minnesota 50
Clinical Trial Overview of University of Minnesota 50
University of Alabama at Birmingham 51
Clinical Trial Overview of University of Alabama at Birmingham 51
Five Key Clinical Profiles 52
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83
List Of Tables
List of Tables
Dermatophytosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Dermatophytosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Dermatophytosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Dermatophytosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Dermatophytosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Dermatophytosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Dermatophytosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Dermatophytosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Dermatophytosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Dermatophytosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Dermatophytosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Dermatophytosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Dermatophytosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Dermatophytosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Dermatophytosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Dermatophytosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Dermatophytosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Dermatophytosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Dermatophytosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Dermatophytosis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Dermatophytosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Dermatophytosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Dermatophytosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Dermatophytosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Dermatophytosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 32
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 33
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2014* 34
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 35
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by York Pharma Plc (Inactive), 2014* 36
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tinea Pharmaceuticals, 2014* 37
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Quinnova Pharmaceuticals, Inc., 2014* 38
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AmDerma Pharmaceuticals, LLC., 2014* 39
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Perrigo Company plc, 2014* 40
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NB Therapeutics, Inc., 2014* 41
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 42
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurdistan University of Medical Sciences, 2014* 43
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oita University, 2014* 44
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jamaica Hospital Medical Center, 2014* 45
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2014* 46
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2014* 47
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014* 48
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 49
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 50
Dermatophytosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 51
List Of Figures
List of Figures
Dermatophytosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Dermatophytosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Dermatophytosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Dermatophytosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Dermatophytosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Dermatophytosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Dermatophytosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Dermatophytosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Dermatophytosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Dermatophytosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Dermatophytosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Dermatophytosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Dermatophytosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Dermatophytosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Dermatophytosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Dermatophytosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Dermatophytosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Dermatophytosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Dermatophytosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Dermatophytosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Dermatophytosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Dermatophytosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 82